Core Laboratories (MEX:CLB) Piotroski F-Score: 8 (As of Jul. 15, 2026) — 33% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CLB Core Laboratories Inc MEX:CLB
62 GF Score
Price MXN856.38
GF Value MXN1,344.78
! 3 Warning Signs
View Full Analysis

What is Core Laboratories Piotroski F-Score?

Core Laboratories MEX:CLB 62 Piotroski F-Score is 8 as of Jul. 15, 2026, which is 33% above its 10-year median of 6.00. GuruFocus rates MEX:CLB with a GF Score™ of 62/100 and a GF Value™ of MXN1,344.78. The stock has 3 warning signs investors should review. Among 971 Oil & Gas companies, Core Laboratories ranks better than 98.46% on this metric.

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Core Laboratories has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Core Laboratories's Piotroski F-Score or its related term are showing as below:

MEX:CLB' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 8
Current: 8

During the past 13 years, the highest Piotroski F-Score of Core Laboratories was 8. The lowest was 2. And the median was 6.

Core Laboratories  (MEX:CLB) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Core Laboratories Piotroski F-Score Related Terms


Core Laboratories Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Core Laboratories's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Laboratories Piotroski F-Score Chart

Core Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 7.00 5.00 7.00

Core Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 7.00 6.00 7.00 8.00

MEX:CLB vs EROK, OIS, NGS: Piotroski F-Score Comparison

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Laboratories Piotroski F-Score vs Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Core Laboratories's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Piotroski F-Score falls into.


MEX:CLB
62GF Score
Core Laboratories Inc MEX:CLB
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 200.267 + 261.203 + 89.092 + -14.228 = MXN536 Mil.
Cash Flow from Operations was 262.159 + 155.962 + 143.073 + 71.5 = MXN633 Mil.
Revenue was 2450.79 + 2467.68 + 2489.378 + 2196.329 = MXN9,604 Mil.
Gross Profit was 429.08 + 477.426 + 451.421 + 287.802 = MXN1,646 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(12101.414 + 11337.268 + 10848.026 + 10515.509 + 10598.323) / 5 = MXN11080.108 Mil.
Total Assets at the begining of this year (Mar25) was MXN12,101 Mil.
Long-Term Debt & Capital Lease Obligation was MXN2,809 Mil.
Total Current Assets was MXN3,866 Mil.
Total Current Liabilities was MXN1,889 Mil.
Net Income was 165.467 + 231.263 + 154.395 + -3.151 = MXN548 Mil.

Revenue was 2392.184 + 2646.317 + 2695.328 + 2528.327 = MXN10,262 Mil.
Gross Profit was 437.429 + 470.913 + 404.058 + 417.327 = MXN1,730 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(9757.768 + 10951.739 + 11823.356 + 12203.296 + 12101.414) / 5 = MXN11367.5146 Mil.
Total Assets at the begining of last year (Mar24) was MXN9,758 Mil.
Long-Term Debt & Capital Lease Obligation was MXN3,444 Mil.
Total Current Assets was MXN4,680 Mil.
Total Current Liabilities was MXN2,122 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Core Laboratories's current Net Income (TTM) was 536. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Core Laboratories's current Cash Flow from Operations (TTM) was 633. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=536.334/12101.414
=0.04431994

ROA (Last Year)=Net Income/Total Assets (Mar24)
=547.974/9757.768
=0.05615772

Core Laboratories's return on assets of this year was 0.04431994. Core Laboratories's return on assets of last year was 0.05615772. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Core Laboratories's current Net Income (TTM) was 536. Core Laboratories's current Cash Flow from Operations (TTM) was 633. ==> 633 > 536 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=2808.503/11080.108
=0.25347253

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=3444.097/11367.5146
=0.30297713

Core Laboratories's gearing of this year was 0.25347253. Core Laboratories's gearing of last year was 0.30297713. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=3865.688/1888.637
=2.04681365

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=4680.182/2122.068
=2.20548163

Core Laboratories's current ratio of this year was 2.04681365. Core Laboratories's current ratio of last year was 2.20548163. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Core Laboratories's number of shares in issue this year was 46.073. Core Laboratories's number of shares in issue last year was 46.773. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1645.729/9604.177
=0.17135555

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1729.727/10262.156
=0.16855396

Core Laboratories's gross margin of this year was 0.17135555. Core Laboratories's gross margin of last year was 0.16855396. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=9604.177/12101.414
=0.79364089

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=10262.156/9757.768
=1.05169092

Core Laboratories's asset turnover of this year was 0.79364089. Core Laboratories's asset turnover of last year was 1.05169092. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Core Laboratories has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 8 mean?
Core Laboratories (MEX:CLB) has a Piotroski F-Score of 8 as of Jul. 15, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Core Laboratories and its competitors. This is 33% above median its historical median of 6.00. Over the past decade, Core Laboratories' Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Core Laboratories ranks #15 out of 971 companies in the Oil & Gas industry, placing it in the top 1.5%.
Is Core Laboratories' Piotroski F-Score too high?
Core Laboratories' current Piotroski F-Score of 8 is 33% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Oil & Gas industry median Piotroski F-Score is 5.00. Core Laboratories' value of 8 is 60% above this industry median. Based on the distribution chart, Core Laboratories ranks #15 out of 971 companies in the Oil & Gas industry, which is in the top quartile — a strong position relative to peers. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Piotroski F-Score compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #15 out of 971 companies for Piotroski F-Score. This places Core Laboratories in the top 2% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Core Laboratories' value of 8 is 60% above this benchmark. Historically, Core Laboratories' own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Core Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for an Oil & Gas company?
The median Piotroski F-Score among Oil & Gas companies is 5.00, based on 971 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current Piotroski F-Score is 8, which is 33% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current Piotroski F-Score of 8. The stock's GF Value™ is MXN1,344.78, compared to a current price of MXN856.38 — trading 36.3% below its estimated fair value. The current Piotroski F-Score is 8, which is 33% above median its 10-year median of 6.00 and 60% above the Oil & Gas industry median of 5.00. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current Piotroski F-Score is 8 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Core Laboratories (MEX:CLB) Overvalued in 2026?

Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued. The current stock price of MXN856.38 is trading 36.3% below its estimated GF Value™ of MXN1,344.78.

Key valuation signals for MEX:CLB:

  • Piotroski F-Score: 8 (33% above median its 10-year median of 6.00)
  • GF Value™: MXN1,344.78 vs. price of MXN856.38 (36.3% below fair value)
  • GF Score™: 62/100 with 3 warning signs
  • Industry Position: 60% above the Oil & Gas median (#15 of 971)

No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Core Laboratories Business Description

Industry EnergyOil & Gas
Other Exchanges CLB:USAHJ1:Germany
Address 6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score

Get the complete analysis for MEX:CLB

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN856.38
Price
MXN1,344.78
GF Value